These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2708806)

  • 1. Multiple prescription rule affects Schedule II drugs.
    Lash A
    Indiana Med; 1989 Mar; 82(3):200-1. PubMed ID: 2708806
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a triplicate prescription law on prescribing of Schedule II drugs.
    Sigler KA; Guernsey BG; Ingrim NB; Buesing AS; Hokanson JA; Galvan E; Doutré WH
    Am J Hosp Pharm; 1984 Jan; 41(1):108-11. PubMed ID: 6695926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triplicate prescription: an idea whose time has yet to come.
    Troisi AJ; Picha N; Evans GE
    Md Med J; 1989 Jan; 38(1):45-6. PubMed ID: 2915609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Dec; 64(232):67720-63. PubMed ID: 11010665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple prescriptions for schedule II drugs.
    Tenn Med; 2008 Jan; 101(1):10. PubMed ID: 18236846
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 7. State program tracks Schedule II drugs.
    Mirro MJ; Winkeljohn HA; Ragatz B
    Indiana Med; 1993; 86(2):148-51. PubMed ID: 8463644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drug dispensing container requirements: final rule.
    Fed Regist; 1978 Aug; 43(166):37985-9. PubMed ID: 10238654
    [No Abstract]   [Full Text] [Related]  

  • 9. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secure prescriptions].
    Audhoui JS
    Ann Pharm Fr; 2000 Mar; 58(2):135-6. PubMed ID: 10790606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Food and Drug Administration, HHS. Final rule; delay of effective date; reopening of administrative record.
    Fed Regist; 2000 May; 65(86):25639-41. PubMed ID: 11010689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing safe and effective preprinted physician's order forms.
    Cohen MR; Davis NM
    Hosp Pharm; 1992 Jun; 27(6):508, 513, 528. PubMed ID: 10118594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The determinant factors in the computerization of the official prescription form].
    Alonso FA; Gancedo Z
    Aten Primaria; 1992 Mar; 9(3):177-8. PubMed ID: 1567978
    [No Abstract]   [Full Text] [Related]  

  • 15. The DEA proposes schedule II substance rule.
    Buchanan BL
    WMJ; 2007 Jul; 106(4):230. PubMed ID: 17844715
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicare program; e-prescribing and the prescription drug program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Nov; 70(214):67567-95. PubMed ID: 16273748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple prescriptions for Schedule II drugs.
    Gerkensmeyer J
    J Pediatr Nurs; 1989 Apr; 4(2):79-80. PubMed ID: 2703949
    [No Abstract]   [Full Text] [Related]  

  • 18. Penetrating the walls of drug-resistant bacteria: a statutory prescription to combat antibiotic misuse.
    Markow SB
    Georgetown Law J; 1998 Nov; 87(2):531-62. PubMed ID: 10346703
    [No Abstract]   [Full Text] [Related]  

  • 19. An American Medical Association perspective on preventing prescription drug diversion.
    Ambre JJ
    NIDA Res Monogr; 1993; 131():224-7. PubMed ID: 8413533
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality control of drug prescriptions by positive lists--the European Formulary.
    Glaeske G
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):403-8. PubMed ID: 7981924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.